1,997
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study

, , , , , & show all
Pages 390-395 | Received 12 Mar 2011, Accepted 26 Mar 2012, Published online: 27 Apr 2012

Figures & data

Table 1. Characteristics of study subjects.

Fig. 1. Kaplan–Meier curves for all-cause hospital readmission among neonates, by maternal codeine prescription. Cumulative proportion of neonates readmitted to hospital for any reason within 30 days of the date of issue for the maternal codeine prescription among exposed neonates (solid line) and the corresponding date among unexposed infants (dashed line).

Fig. 1. Kaplan–Meier curves for all-cause hospital readmission among neonates, by maternal codeine prescription. Cumulative proportion of neonates readmitted to hospital for any reason within 30 days of the date of issue for the maternal codeine prescription among exposed neonates (solid line) and the corresponding date among unexposed infants (dashed line).

Table 2. Association between maternal medication use and neonatal readmission to hospital for any reason.

Table 3. Association between maternal codeine exposure and secondary neonatal outcomes.

Supplemental material

http://www.informahealthcare.com/doi/abs/10.3109/15563650.2012.681052

Download PDF (124.6 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.